TRANQUILLO and TRANQUILLO 2 together enrolled 2,174 patients across 271 sites worldwide, the largest Phase 3 program to date for an oral systemic therapy in this indication
Treatment may involve dosage calculations, cycle length, delivery method, medication interactions, product quality concerns, and ongoing monitoring
New blood vessel growth serves healing purposes, but uncontrolled angiogenesis has implications for conditions involving abnormal vascular proliferation
Until the agency takes its own action, the advisory committee's recommendations do not themselves make the six peptides FDA-approved medicines, or automatically permit their use in compounding.
Many patients in their sixties and seventies are subtly low without knowing it